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Abstract 32 
PURPOSE We aimed to measure 1) the dynamics of locomotor fatigue during constant 33 
supra-critical power cycling, and 2) the magnitude of any reserve in locomotor power at 34 
intolerance to constant and ramp-incremental cycling in recreationally-active volunteers. 35 
METHODS Fifteen participants (7 women and 8 men, 22±3 yr, 3.34±0.67 L.min-1 36 
V̇O2peak) completed ramp-incremental and very-heavy constant power (205±46 W) 37 
exercise to the limit of tolerance. Immediately following intolerance, the ergometer was 38 
switched into the isokinetic mode and participants completed a short (~5 s) maximal 39 
isokinetic effort at 70 rpm. The time course of locomotor fatigue during constant supra-40 
critical power exercise was characterized with these short maximal isokinetic sprints at 41 
30, 60, 120, 180 s and at the limit of tolerance. Each bout was terminated following the 42 
isokinetic sprint.  43 
RESULTS Constant power exercise duration was 312±37 s. Isokinetic power production 44 
at 30, 60, 120, 180 s and the limit of tolerance (at 312±37 s) was 609±165, 503±195, 45 
443±157, 449±133, and 337±94 W, respectively. Of the total decline in isokinetic power, 46 
~36% occurred within the first minute of exercise and significant (p<0.05) reductions in 47 
isokinetic power occurred at all time-points vs the baseline maximal isokinetic power 48 
(666±158 W). Additionally, a significant power reserve of 132±74 W (64% of the task 49 
requirement) and 119±80 W (47%) was present at the limit of constant power and ramp-50 
incremental exercise, respectively.  51 
CONCLUSIONS Locomotor fatigue occurred rapidly during supra-critical power 52 
exercise with pseudo-exponential kinetics. Instantaneous isokinetic power production at 53 
the limit of tolerance exceeded that of the task requirement, regardless of the constant, 54 
2 
 
or ramp work rate profile. Thus, the perceptual and physiologic limits were dissociated 55 
at the limit of tolerance in recreationally-active volunteers.  56 
 57 
Abstract word count: 275 (275 max). 58 
 59 
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Abbreviations 62 
CI95, 95% confidence interval 63 
Piso, isokinetic power 64 
V̇O2peak, peak oxygen uptake  65 
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Introduction 66 
Exercise intolerance worsens quality of life and is a powerful predictor of mortality (1-3). 67 
Improving exercise tolerance has consistent positive impacts on healthy people and 68 
those with disease (4-6). Therefore, understanding the mechanisms of exercise 69 
intolerance is crucial for identifying effective prevention and rehabilitation strategies for 70 
chronic conditions that impact physical function.  71 
 72 
Fatigue is a loss in the capacity for developing force and/or velocity that is reversible by 73 
rest (7). Fatigue plays a crucial role in determining exercise intolerance. Some of the 74 
mechanisms contributing to fatigue during dynamic, whole-body exercise include 75 
heightened perception of exertion or dyspnea, inhibitory afferent signals from the 76 
skeletal muscle environment, reduced membrane excitability, and local muscle 77 
metabolic and ionic factors that directly inhibit cross-bridge function (7-14). Collectively, 78 
the mechanisms are often grouped as ÔcentralÕ and ÔperipheralÕ according to the 79 
placement with the hierarchy of the neuromuscular system. Typically, central 80 
components are ÔnorthÕ of the neuromuscular junction to include the motor and spinal 81 
nerves, spinal cord, brain stem, and brain.  82 
 83 
The dynamics, or rate of accumulation, of locomotor fatigue may provide information 84 
about how the intracellular environment underpins intolerance, as the dynamic behavior 85 
of key fatigue-related metabolites is well established in the literature. For example, the 86 
time-course of inorganic phosphate (Pi) conforms to a pseudo-exponential profile with a 87 
half-time of approximately 30 s. Thus, for constant power exercise most of the change 88 
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in [Pi] occurs within the first 2-3 minutes of contraction (10, 15, 16). Pi elicits substantial 89 
reductions in force, particularly when concentrations rise to ~10-20 mM during high-90 
intensity exercise (12, 13). During high-intensity contraction, reductions in muscle power 91 
behave with similar dynamics to Pi (15, 17, 18). Muscle power also recovers with similar 92 
dynamics to the intramuscular phosphates (17, 20). However, data from the literature on 93 
the time-resolution for muscle power measurements during dynamic, large muscle mass 94 
exercise is poor (19). Thus far, there are no data on the initial, rapid dynamics of 95 
locomotor fatigue during whole-body, dynamic exercise. Therefore, the time-course of 96 
fatigue during the first ~3 min of high-intensity exercise is unknown. 97 
 98 
Ideally, measurement of locomotor fatigue is applicable to whole-body, large muscle 99 
mass, dynamic exercise (walking, running, cycling). Additionally, it is critical that 100 
contraction velocity be controlled for unless the majority of the power-velocity 101 
relationship is measured (21, 22) - locomotor power is dependent on the parabolic 102 
relationship of power and contraction velocity. Assessing fatigue using a combination of 103 
cadence-independent cycling tasks followed immediately by a maximal isokinetic effort 104 
allows the contraction velocity-specific decline in task-specific power to be measured in 105 
accordance with these criteria. The recovery of skeletal muscle power following a bout 106 
of high-intensity exercise is rapid, with most of the recovery occurring within the first two 107 
minutes of recovery and nearly full recovery somewhere between 3 and 8 minutes (20, 108 
23-25). In fact, even 5-10 s of rest results in substantial recovery when measuring 109 
neuromuscular function (20, 25, 26). These data show the importance of rapidly 110 
measuring locomotor fatigue (27), and highlight one of the key drawbacks of using 111 
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electrical stimulation, transcranial magnetic stimulation, or single-joint maximal voluntary 112 
contraction, particularly when following whole-body exercise. This approach requires, at 113 
minimum, a 1-2 min delay from the time of interest following cycling (28), save for the 114 
most recent innovation using a cycle ergometer capable of near-instantaneous 115 
measurement (27). Knee-extension exercise, of course provides near instantaneous 116 
assessment of neuromuscular fatigue (11, 24) with the drawback of being somewhat 117 
less taxing to the cardiopulmonary system. 118 
 119 
Exercise intolerance should arise when the reduction in maximal evocable locomotor 120 
power is sufficient enough to constrain the exercise task (29). This is a contentious 121 
issue, however, during whole-body exercise even in healthy people. Some evidence 122 
shows there is a large ÔreserveÕ in locomotor power (8), and some that there is little to 123 
no  meaningful reserve at the limit of tolerance in healthy people (22, 23, 30). Further 124 
complicating the matter is the task profile (constant vs variable vs ramp) and task 125 
duration to intolerance appears to affect the size of the reserve (8, 31). Whether or not 126 
the limit of tolerance is consistently accompanied by a ÔreserveÕ in locomotor power 127 
remains uncertain, and is likely variable across health and disease (30).  128 
 129 
The purposes of this study are twofold. Firstly, we aimed to measure the dynamics of 130 
locomotor fatigue at the onset of high-intensity cycling. Second, we aimed to measure 131 
the reserve in locomotor power at intolerance to constant and ramp-incremental cycling. 132 
 133 
Materials and Methods 134 
Participants 135 
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Fifteen healthy, recreationally active volunteers took part in this study (7 women, 8 men, 136 
22±3 yr, 173±12 cm, 66±12 kg, 3.34±0.67 L.min-1 V̇O2peak). Volunteers provided written 137 
informed consent and were screened for cardiovascular risks with the Physical Activity 138 
Readiness Questionnaire (PAR-Q) prior to beginning the study. The San Diego State 139 
University Institutional Review Board approved the protocol. 140 
 141 
Exercise tests 142 
Participants completed 6 laboratory visits, each separated by a minimum of 24 hours. 143 
Within each laboratory visit the participants completed two experimental phases: 1) 144 
short (~5 s) bouts of maximal effort isokinetic cycling at 70 rpm (measured in triplicate) 145 
to determine maximal isokinetic power at baseline (Figure 1A, Figure 2A); and 2) a 146 
ramp-incremental or constant power exercise test, terminated with a short (~5 s) 147 
maximal isokinetic effort at 70 rpm (Figure 1B). 148 
 149 
Visit 1 150 
The first laboratory visit included a ramp-incremental test to the limit of tolerance. The 151 
ramp test began with 1 min rest and a 2 min warm-up phase at 25 W.  Following the 152 
warm-up, power was increased at 25 W.min-1 until intolerance.  Each participant was 153 
instructed to maintain a cadence > 70 rpm. Failure to maintain > 60 rpm, despite strong 154 
verbal encouragement, marked the termination of the ramp-incremental phase. 155 
Immediately following intolerance, the cycle ergometer was switched from hyperbolic to 156 
isokinetic mode (70 rpm) and the participant was instructed to give a maximum effort for 157 
5 s. Participants then completed a 5 min recovery phase at 20 W (Figure 1A).  158 
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 159 
Visits 2-6 160 
During the second visit (Figure 1B), participants completed a constant power exercise 161 
test to the limit of tolerance. To assign each participantÕs constant power, 2 min worth of 162 
ramp incrementation (50 W) was subtracted from peak ramp power. This was a 163 
modified approach (32) to estimate an ~6 min duration exercise test, based on our pilot 164 
testing. Following completion of warm-up at 20 W, power was increased abruptly to the 165 
assigned constant power and participants were instructed to maintain the power until 166 
the limit of tolerance. Failure to maintain > 60 rpm, despite strong encouragement, 167 
marked the end of the constant power phase. The cycle ergometer was immediately 168 
switched from hyperbolic to isokinetic mode where participants were again strongly 169 
encouraged for 5 s of maximal effort cycling. Participants then completed a 5 min active 170 
recovery phase of light cycling at 20 W. 171 
 172 
The remaining 4 visits were completed in random order and consisted of constant 173 
power cycling at the same work rate during visit 2. However, the durations of the final 4 174 
visits were 30, 60, 120, and 180 s (Figure 1B). These tests were completed with 175 
essentially the same format, yet halted at the pre-determined times rather than 176 
continued to the limit of tolerance. Within the final ~5 s of the exercise bout, participants 177 
were instructed to decelerate to ~ 70 rpm to avoid an overcompensation of the flywheel 178 
braking action at the onset of the isokinetic cycling. At the completion of the pre-179 
determined constant power cycling, the cycle ergometer was switched from hyperbolic 180 
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to isokinetic mode where participants gave a maximal effort for 5 s. A 5 min active 181 
recovery phase at 20 W followed, marking the end of the test. 182 
 183 
Ergometry 184 
The computer-controlled electromagnetically-braked cycle ergometer (Excalibur Sport 185 
PFM, Lode BV, Groningen, NL) is instrumented with force transducers in the bottom 186 
bracket spindle. Left and right torque (Nm) was measured independently (peak force 187 
2000 N, < 0.5 N resolution and measurement uncertainty of < 3%). Instantaneous 188 
angular velocity of the crank (rad.s-1) was measured with a resolution of 2¡ using three 189 
independent sensors sampling in series (measurement uncertainty of < 1%). During 190 
isokinetic efforts, power was calculated every 2¡ from torque and angular velocity 191 
measurements. 192 
 193 
Cardiopulmonary Measurements 194 
Respired gases and ventilation were measured breath-by-breath with a commercial 195 
metabolic measurement system (VMax Spectra, CareFusion, San Diego, CA USA). The 196 
system was calibrated immediately prior to each experiment. A 3 L syringe (Hans 197 
Rudolph Inc., Shawnee, KS, USA) was used to calibrate the mass flow sensor from 198 
~0.2 to 8.0 L.s-1, mimicking flow rates expected at rest and during exercise. The CO2 199 
and O2 analysers were calibrated using gases of known concentrations (O2 26.0% and 200 
16.0%; CO2 0.0% and 4.0%).  201 
 202 
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Statistical analyses 203 
A Wilcoxon test was used to assess task power vs. isokinetic power at exercise 204 
intolerance. This was due to a violation in the assumption of equal variance in each 205 
attempt to use the paired t-test. A one-factor (time) repeated measures analysis of 206 
variance was performed to analyze the reduction in isokinetic power over time. In this 207 
case, all BartlettÕs and Brown-Forsythe tests were non-significant. Post hoc t-tests were 208 
used to determine the location of differences in the event of a significant omnibus test. 209 
Statistical tests were considered significant at p<0.05. All data was analyzed using the 210 
Statistical Package for the Social Sciences (SPSS v22. SPSS Inc, Chicago, IL, USA). 211 
Results are reported as mean ± SD. 212 
 213 
Results 214 
Oxygen uptake during ramp-incremental and constant power exercise 215 
V̇O2peak during ramp-incremental and constant power exercise was 3.3 ± 0.7 L/min and 216 
3.4 ± 0.7 L/min, respectively. V̇O2peak was not different between ramp-incremental and 217 
constant power exercise (p>0.05). 218 
 219 
Time course of locomotor fatigue during constant power exercise to intolerance 220 
Constant power exercise duration was 312 ± 37 s. Maximal isokinetic power output 221 
declined (F[5,84]=10.2, p<0.05) throughout heavy constant power exercise (Figure 2B). 222 
Piso at 30, 60, 120, 180 s, and the limit of tolerance was 609 ± 165, 503 ± 195, 443 ± 223 
157, 449 ± 133, and 337 ± 94 W, respectively. Of the total decline in isokinetic power, 224 
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~36% occurred within the first minute of exercise and reductions (p<0.05) in isokinetic 225 
power occurred at the final 3 time-points vs the baseline Piso (666 ± 158 W; Figure 2B).  226 
 227 
The dynamics of locomotor fatigue were similar when the participants were split based 228 
on sex (Figure 2C, 2D). For men and women, the constant power tolerance was 323 ± 229 
36 and 299 ± 38 s, respectively. The total decline in Piso at the limit of tolerance was 230 
~50% of the baseline power for both men and women. The dynamics appeared 231 
somewhat different for men as Piso declined (F[5,42]=25.6, p<0.05) such that by 60 s 232 
~30% of the total decline in Piso had occurred (Figure 2C). For women, the same 233 
measurement in Piso decline (F[5,36]=19.7, p<0.05) equaled ~48% (Figure 2D). 234 
 235 
Isokinetic power and power reserve following intolerance  236 
 At baseline, participants generated a maximum isokinetic (70 rpm) power of 666 237 
± 158 W. Constant power (205 ± 46 W) exercise duration was 312 ± 37 s. At 238 
intolerance, participants generated an isokinetic power of 337 ± 94 W, and this was 239 
greater than the required constant power (p<0.05; Figure 3A). This resulted in a power 240 
reserve of 132 ± 74 W or (64 ± 35% of the constant power). During ramp-incremental 241 
exercise, participants achieved a peak power of 254 ± 47 W. At intolerance, participants 242 
generated a maximal isokinetic (70 rpm) power of 373 ± 101 W, and this was greater 243 
than peak ramp power (p<0.05; Figure 3B). Therefore, participants exhibited a reserve 244 
for instantaneous power of 119 ± 80 W (or 47 ± 31% of ramp peak power). Additionally, 245 
there was no difference (p>0.05) in the magnitude of the power reserve at intolerance 246 
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between ramp-incremental and constant power exercise (Figure 3). These same 247 
findings were extended when the analysis was split based on sex (Figure 3C-F). 248 
 249 
Discussion 250 
We aimed to measure the dynamics of locomotor fatigue during high-intensity exercise 251 
and the reserve in locomotor power at intolerance to constant and ramp-incremental 252 
cycling. Our major findings are: 1) locomotor fatigue occurs pseudo-exponentially and 253 
rapidly, with ~36% of total fatigue accumulating within the first minute of exercise, and 254 
2) a 47 ± 31% and 64 ± 35% locomotor power reserve is present at the limit of tolerance 255 
in ramp-incremental and constant power exercise, respectively. Therefore, locomotor 256 
fatigue accumulates rapidly during high-intensity exercise, following an approximately 257 
exponential profile. However, at the limit of tolerance, participants exhibited a reserve 258 
for instantaneous power production that exceeds the task requirement. 259 
 260 
Locomotor fatigue within the first minutes of high-intensity exercise  261 
Similar to knee-extension exercise (24), approximately half of the locomotor fatigue 262 
occurred early in the cycling bout. At the onset of high-intensity exercise, the finite 263 
kinetics of oxidative phosphorylation necessitates that glycolysis and phosphocreatine 264 
breakdown make substantial contributions to maintain ATP concentration (~8.2 mM), 265 
with the greatest contribution at the start of the exercise bout (33). During the initial ~10 266 
s of high-intensity exercise, [PCr] rapidly falls while [Pi] rises. Pi concentration is tightly 267 
correlated to force production, such that high [Pi] decreases ATPase activity and power 268 
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production (13). During the first 30 s of exercise in our experiment, significant fatigue 269 
has already accumulated (Figure 2B).  270 
 271 
In addition to depletion of the finite PCr stores, glycolysis contributes substantially to 272 
ATP resynthesis during high-intensity exercise, and is activated within seconds of 273 
exercise onset (34). While lactate is the preferred fuel of mitochondrial oxidative 274 
phosphorylation, the associated acidosis may be detrimental to muscle function (35). 275 
This occurs due to an acidic muscular environment reducing the number of high-force 276 
cross bridges in fast fibers, the force per cross bridge in both fast and slow fibers, and 277 
myofibrillar Ca2+ sensitivity (14, 36). 278 
 279 
Continual depletion of the finite energy (PCr, glycogen) sources leads to raised 280 
concentrations of Pi, ADP, and lactate in working skeletal muscles. The additive effects 281 
of Pi and H+ decrease power through cross-bridge disruption when elevated above 282 
resting concentrations (13). Locomotor fatigue accumulates with a similar time course to 283 
that of intramuscular metabolites. We feel this kinetic association suggestions the 284 
decline in voluntary power being explained by the accumulation of phosphate and 285 
fatigue-related intramuscular metabolites. However, there is clearly a complex 286 
interaction of many fatigue-inducing mechanisms in skeletal muscle and our study does 287 
not offer mechanistic insight into these mechanisms. In addition to the changes in high-288 
energy phosphates, low pH, plasma membrane excitability through loss of intracellular 289 
K+ (37), and cross bridge sensitivity to suboptimal Ca2+ (35, 36) are critically important 290 
in the fatigue process. While the dynamics of increased interstitial K+ or reduced 291 
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intracellular Ca+ and pH may not match with the kinetics of locomotor fatigue, they likely 292 
work synergistically with the phosphate changes to reduce force output. This is 293 
particularly true in experiments completed at near physiologic temperatures (35). 294 
 295 
We do want to highlight an important limitation in this section, in that the nature of the 296 
exercise in our current experiment is substantially different to that of most experiments 297 
where 31P MRS was used to measure instramuscular metabolites. In most examples, 298 
knee extension is generally the exercise mode (15). Perhaps the closest design might 299 
be that of Rodenburg et al., where the ergometer required hip and knee extension (38). 300 
However, even in this case there appears to be a rapid increase in the Pi/PCr ratio with 301 
increasing power output. This suggests that exercise similar to cycling should be no 302 
different to isolated muscle experiments or single-leg knee extension. 303 
 304 
Total locomotor fatigue accumulation at limit of tolerance 305 
Constant power exercise was maintained for 312 ± 37 s. Progressive reduction in 306 
maximal isokinetic power output is seen up until this point (Figure 2B). While women 307 
exhibited lower Piso generation at baseline, the relative reduction in Piso at the limit of 308 
tolerance was similar to men (~50% of baseline Piso). The dynamics of locomotor fatigue 309 
accumulation appeared to be somewhat faster in women, however we would need a 310 
larger sample size to be sure about sex differences. 311 
 312 
Critical power represents the highest work rate that will elicit a metabolic steady-state, 313 
and therefore demarcates unpredictably-sustainable from predictably-unsustainable 314 
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exercise. While fatigue related metabolites reach a plateau at ~2-3 min during sub-CP 315 
exercise, continual accumulation up to intolerance is seen in supra-CP exercise (15). 316 
Similarly, participants performing sub-CP exercise were able to maintain voluntary 317 
velocity-specific peak power between 3 and 8 min of exercise (19). Together, this lends 318 
support to the close linkage between the intramuscular environment, locomotor fatigue, 319 
and exercise tolerance (14). Our data show a continual accumulation of locomotor 320 
fatigue during supra-CP exercise, and fit closely with this assertion that the 321 
intramuscular events underpin the reduction in voluntary muscle power.  322 
 323 
In addition to peripheral contributors to fatigue and the fall in isokinetic power 324 
production, afferent feedback (including conscious perception of effort) and efferent 325 
feed-forward mechanisms may modulate exercise tolerance. Muscle force production 326 
falls progressively and evoked peak power reaches an approximate plateau (at ~40% of 327 
time trial) during non-sustainable exercise (24). However, by intolerance, it appears as 328 
though peripheral locomotor fatigue is ÔregulatedÕ to some maximal value (28, 39). 329 
Additionally, early accumulation of peripheral fatigue is compensated for by increased 330 
motor drive, and task failure therefore may be due, ultimately, to increased central 331 
fatigue arising late in the exercise task (40). Therefore, in addition to intramuscular 332 
fatigue-related metabolite buildup, central regulation and emotional responses to 333 
exercise likely play a role in the development of locomotor fatigue (41). As we did not 334 
measure contributions of ÔcentralÕ and ÔperipheralÕ mechanisms of fatigue, we can only 335 
provide speculation as to the origin of locomotor fatigue in our data. Therefore, the close 336 
dynamic association of our locomotor power data to the buildup of intramuscular 337 
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metabolites may only be coincidental, and not causal. A new approach is now available 338 
that may provide some insight into the fatigue-mechanisms through instantaneous 339 
assessment of neuromuscular fatigue following cycling exercise, albeit isometric (27). 340 
Finally, our data only provide insight for a single contraction velocity. The shape of the 341 
power-velocity relationship (42) suggests that the magnitude of change will be larger at 342 
high contraction velocities, but the dynamics of the fatigue at those contraction 343 
velocities is unknown. 344 
 345 
A reserve in locomotor power generating capacity at the point of intolerance 346 
Brief maximum isokinetic power at the limit of tolerance (and at 70 rpm) was higher than 347 
the task power in both ramp-incremental and constant power exercise (Figure 3). This 348 
represents a temporary separation between perceptual and physiological limits of power 349 
production. It is important to note that there was no difference in V̇O2peak in ramp and 350 
constant power exercise, showing individuals did attain systems limits in both exercise 351 
test formats. Additionally, the reserve in locomotor power represents a near-352 
instantaneous (~5 s) capacity for power production. This is in contrast to a sustained 353 
(>30s) maximal isokinetic effort in which power output falls nearer to critical power 354 
immediately following intolerance (43). Finally, the contraction velocity likely influences 355 
the magnitude of the power reserve, as power generation is a parabolic function of 356 
velocity (42, 44). While the portion of the power-velocity relationship that encompasses 357 
cycling becomes flatter with muscle fatigue (45), the absolute isokinetic power 358 
generated at intolerance at 70rpm is likely to be less than that of higher contraction 359 
velocities. This is especially true for short bursts of sprint type exercise. Conversely, 360 
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during longer, incremental exercise protocols there are surprisingly negligible benefits 361 
across a range of 40-120rpm for V̇O2peak or peak power achieved during the incremental 362 
test (42, 44). This is of course in contrast to higher selected pedaling frequencies in 363 
competitive cycling where both efficiency-velocity, and power-velocity relationships must 364 
be considered. The relevancy of the ÔreserveÕ in locomotor power in our experiment, 365 
therefore, is that the power output is constrained to the contraction velocity similar to 366 
that used by our volunteers during the constant or ramp task. However, this design 367 
decision to make isokinetic measurements only at 70rpm is also a weakness of our 368 
study Ð a more complete measurement of the power-velocity relationship would clearly 369 
have been a more desirable choice. We did not choose this design due to the 370 
substantial burden on research volunteers, as it would require many-fold more visits to 371 
the laboratory. 372 
 373 
Additional recruitment of motor units is responsible for the instantaneous increase in 374 
force production, suggesting that the limit of tolerance during the exercise task is not 375 
defined by a ceiling of motor recruitment and power production Ð this is in contrast to 376 
single limb exercise (29). Exercise tolerance may in some circumstances therefore be 377 
limited by perception of effort, rather than neuromuscular fatigue that ÔcapsÕ power 378 
production sufficient to continue the task (8). However, these perceptual effects may be 379 
dependent on the population studied (chronic cardiopulmonary disease vs healthy vs 380 
athlete). Contrary to our findings, no reserve was present following whole body exercise 381 
in men with VO2max 4.2 ± 1.0 L/min (22). It is possible that highly-trained individuals 382 
maintain a close association of perceptual and physiologic limits and exhibit central and 383 
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peripheral fatigue mechanisms different to that of our recreationally-active participants - 384 
and certainly to that of patients with cardiopulmonary disease (30). No research has 385 
examined oxidative capacity as a modifier of the locomotor power reserve, or the 386 
mechanisms that underpin this phenomenon.  387 
 388 
Conclusions 389 
We aimed to measure 1) the dynamics of locomotor fatigue at the onset of high-intensity 390 
cycling, and 2) the reserve in locomotor power following constant and ramp-incremental 391 
cycling to the limit of tolerance. Maximal voluntary isokinetic power fell progressively 392 
during constant power exercise. However, ~36% of the total fatigue occurred in the first 393 
60 s of exercise, showing rapid, approximately exponential kinetics.  394 
 395 
The dynamics of locomotor fatigue were similar to the dynamics reported for primary 396 
fatigue-related intramuscular metabolites, suggesting a close mechanistic link between 397 
the intramuscular milieu and voluntary muscle power. Instantaneous isokinetic power 398 
production at the limit of tolerance exceeded that of the task requirement, regardless of 399 
the work rate profile. Thus, the perceptual and physiologic limits were dissociated at the 400 
limit of tolerance in recreationally active volunteers. While the dynamics of locomotor 401 
fatigue may reflect the disturbances in the intramuscular metabolic environment, the 402 
limit of tolerance may be predominantly determined by mechanisms limiting voluntary 403 
motor unit recruitment. 404 
18 
 
 405 
Competing Interests 406 
Authors have no competing interests. 407 
 408 
Funding 409 
ARS and SY were supported by the SDSU Summer Undergraduate Research Program.  410 
 411 
Acknowledgements 412 
The results of the study are presented clearly, honestly, and without fabrication, 413 
falsification, or inappropriate data manipulation. The results of the present study do not 414 
constitute endorsement by ACSM. Thank you to our volunteers for your time and 415 
dedication. 416 
  417 
19 
 
 418 
Figure 1. Schematic of the exercise testing protocols. Panel A: Visit 1 consisted of 419 
ramp-incremental exercise terminated with a maximal isokinetic effort at the limit of 420 
tolerance. Filled and open symbols represent 5 s maximal isokinetic power (Piso) 421 
measured either in triplicate at baseline (filled) or at the termination of the exercise test 422 
(open). Panel B: Visits 2-6 were variable duration constant power tests terminated with 423 
Piso. Constant power tests were terminated with maximal Piso at either predetermined 424 
times (30, 60, 120, 180 s; shaded symbols) or at the limit of tolerance (open symbol).  425 
 426 
Figure 2. Construction of the dynamics of locomotor fatigue during constant supra-427 
critical power exercise. Panel A: Representation of a single Piso, in this case at baseline 428 
with no prior exercise. Dashed line and filled symbol represents mean during maximal 429 
effort. Panel B: The dynamics of locomotor fatigue are presented as the reduction in 430 
maximal Piso during exercise as a function of time (F[5,84]=10.2, p<0.05). Solid circle is 431 
the baseline mean as measured in Panel A. Lines represents mean (solid) and SD 432 
(dashed) constant power task requirement. Panel C: The dynamics of locomotor 433 
fatigue, as in Panel B, however with only the men included (F[5,42]=25.6, p<0.05). 434 
Panel D: Only the women included (F[5,36]=19.7, p<0.05). *Different to baseline Piso 435 
(p<0.05).  436 
 437 
 438 
Figure 3. Comparison between task requirement and maximal isokinetic power (Piso) at 439 
the limit of tolerance. Panel A: Piso at intolerance to constant power exercise was 440 
greater (p<0.05) than the task requirement. Panel B: Piso at intolerance to ramp 441 
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incremental exercise was greater (p<0.05) than the peak power achieved during the 442 
ramp. Panel C: Piso at intolerance to constant power exercise was greater (p<0.05) than 443 
the task requirement in men only. Panel D: Piso at intolerance to ramp incremental 444 
exercise was greater (p<0.05) than the peak power achieved during the ramp in men 445 
only. Panel E: Piso at intolerance to constant power exercise was greater (p<0.05) than 446 
the task requirement in women only. Panel F: Piso at intolerance to ramp incremental 447 
exercise was greater (p<0.05) than the peak power achieved during the ramp in women 448 
only. 449 
 450 
  451 
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